Suxethonium chloride

Suxethonium chloride
Identifiers
	IUPAC name 2,2’-[(1,4-Dioxo-1,4-butanediyl)bis(oxy)]bis(N-ethyl-N,N-dimethylethanaminium) dichloride;
CAS Number	54063-57-9;
PubChem CID	71732;
ChemSpider	64776;
UNII	U5026H7S5S;
KEGG	D08553;
ChEMBL	ChEMBL2107598;
CompTox Dashboard (EPA)	DTXSID20218004 ;
ECHA InfoCard	100.053.581
Chemical and physical data
Formula	C16H34Cl2N2O4
Molar mass	389.36 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)CC.[Cl-].[Cl-];
	InChI InChI=1S/C16H34N2O4.2ClH/c1-7-17(3,4)11-13-21-15(19)9-10-16(20)22-14-12-18(5,6)8-2;;/h7-14H2,1-6H3;2*1H/q+2;;/p-2; Key:BHCKTCGQZMCGAB-UHFFFAOYSA-L;

Suxethonium (trade name: Brevidil-E) is a depolarising muscle relaxant which is presented as a dry powder in an ampoule. This is re-constituted with sterile water prior to use. It is available in Australia as a schedule 4 drug,^[1] and the US.^[2]

^ [1]^{[dead link]}
^ "Suxethonium Chloride". Drugs.com.

[1] [1]^{[dead link]}

[2] "Suxethonium Chloride". Drugs.com.

[1]

[2]

Identifiers

IUPAC name 2,2’-[(1,4-Dioxo-1,4-butanediyl)bis(oxy)]bis(N-ethyl-N,N-dimethylethanaminium) dichloride
CAS Number	54063-57-9
PubChem CID	71732
ChemSpider	64776
UNII	U5026H7S5S
KEGG	D08553
ChEMBL	ChEMBL2107598
CompTox Dashboard (EPA)	DTXSID20218004
ECHA InfoCard	100.053.581
Chemical and physical data
Formula	C₁₆H₃₄Cl₂N₂O₄
Molar mass	389.36 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)CC.[Cl-].[Cl-]
InChI InChI=1S/C16H34N2O4.2ClH/c1-7-17(3,4)11-13-21-15(19)9-10-16(20)22-14-12-18(5,6)8-2;;/h7-14H2,1-6H3;2*1H/q+2;;/p-2 Key:BHCKTCGQZMCGAB-UHFFFAOYSA-L